New Memorandum of Understanding signed to create partnership in neuroscience research

Published on December 16, 2013 at 11:31 PM · No Comments

Partnership to include the Feinstein Institute, Cold Spring Harbor Lab, Penn Medicine, Temple University, and Israel Brain Technologies

Today, Congressmen Steve Israel (D-NY) and Chaka Fattah (D-PA) announced the signing of a Memorandum of Understanding (MOU) dedicated to creating a partnership in neuroscience research, and in particular, research on Alzheimer's disease. Signers of the MOU included the Feinstein Institute in Manhasset, Cold Spring Harbor Lab in Cold Spring Harbor, Penn Medicine in Philadelphia, Temple University in Philadelphia, and Israel Brain Technologies in Ramat Hasharon, Israel. Representatives from all the institutions were present. Both Reps. Israel and Fattah have been leaders in Congress on the issue of neuroscience and Alzheimer's research.

Rep. Israel said, "I was thrilled to join my colleague, Rep. Fattah, to announce a revolutionary global partnership between five world-class research institutions in neuroscience. I am confident that groundbreaking research will come from this partnership that will bring us closer to understanding the brain and finding a treatment, cure or prevention method for Alzheimer's disease. Both Rep. Fattah and I have been staunch advocates in Congress for more research for neuroscience and Alzheimer's disease, and today's announcement is an important step forward."

Rep. Fattah said, "Understanding that significant advancements in neuroscience require a sharing of resources, research, and strengthened communication, Rep. Israel and I are thrilled to see such a partnership formalized today. This is an international challenge that one organization or one country cannot solve on its own—rather it calls for global commitment, and most importantly, collaboration. Together these leading institutions from our districts, and Israel, will build extraordinary teams of researchers and doctors dedicated to discovering new treatments and cures. I look forward to joining them and Rep. Israel in our continued fight against brain disease."

Dr. Peter Davies, Director of the Litwin-Zucker Research Center for the Study of Alzheimer's Disease at the Feinstein Institute for Medical Research said, "It is absolutely essential that scientists involved in neuroscience and Alzheimer's disease collaborate. We will not cure Alzheimer's disease by ourselves. This collaboration represents a concrete step in bringing together five groups that have real interest and commitment to finding effective treatments."

Cold Spring Harbor Lab Associate Professor Josh Dubnau, Ph.D. said, "Science is at its best when researchers with different ideas come together and collaborate. In order to overcome the great challenge of defeating Alzheimer's disease we need science at its best. Congressmen Israel and Fattah understand this, and Cold Spring Harbor Laboratory is proud to be part of this historic collaborative research effort."

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post